Skip to main content
OpenTrials

Clinical trial condition

Platinum-Sensitive Ovarian Cancer in First Relapse

Explore clinical trials studying Platinum-Sensitive Ovarian Cancer in First Relapse. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Platinum-Sensitive Ovarian Cancer in First Relapse trial results

Completed

A Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Participants With Low CA125 Platinum-sensitive Ovarian Cancer

NCT02289950

Conditions
Platinum-Sensitive Ovarian Cancer in First Relapse
Locations
  • Phoenix, Arizona, United States
  • Los Angeles, California, United States
  • Orange, California, United States
  • Roseville, California, United States
View all 68 locations
View Trial Details